Alyeska Investment Group
WX

Alyeska Investment Group’s WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS WX Stock Holding History

Alyeska Investment Group’s Portfolio WX Stock Details WX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-217,771
Closed -$9.41M – 552
2015
Q3 		$9.41M Buy
217,771
+203,249
+1,400% +$8.58M 0.11% 210
2015
Q2 		$614K Buy
+14,522
New +$612K 0.01% 442

Other funds holding WX

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
CCS
Crosspoint Capital Strategies Orinda, California $50.4M AUM 15.37% 1-Year Est. Return

Alyeska Investment Group's WX Position: Q4 2015 in Review

Alyeska Investment Group sold out of WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS (WX) in Q4 2015, closing a stake of 217,771 shares — an estimated $9.41M sold.

Alyeska Investment Group first reported a position in WX in Q2 2015 and held it in 2 quarters. The position peaked at $9.41M in Q3 2015. 2 funds tracked by Wall St. Rank hold WX as of Q4 2015.

  • Alyeska Investment Group reported no remaining WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position as of Q4 2015 after selling out during the quarter.
  • Alyeska Investment Group sold 217,771 WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS shares in Q4 2015, an estimated $9.41M.
  • Alyeska Investment Group first reported a position in WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS in Q2 2015 and held it in 2 quarters.
  • Alyeska Investment Group's WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS position peaked at $9.41M in Q3 2015.
  • 2 funds tracked by Wall St. Rank held WUXI PHARMATECH, CAYMAN INC REPSTG 8 ORD SHS as of Q4 2015.

Based on Alyeska Investment Group's 13F filing for Q4 2015, filed 16 Feb 2016.